Tag Archives: TAG

Advocates, physicians to pharmaceutical company: lower price on government-supported drug, aid research

By on .

It has been heralded as an important step in ending the threat of tuberculosis in the United States, and one with ramifications for countries with higher incidence of the disease: a new drug to treat TB infection before it causes illness, treat it more quickly than current regimens. With standard treatment consisting of daily pills […]

With TB research threatened, doctors, patients, advocates and filmmakers spell out risks

By on .

At a recent conference of medical researchers, National Institute of Allergy and Infectious Diseases Director Anthony Fauci spelled out what lawmakers appear to be missing in their budget balancing efforts. “They don’t realize,” Fauci said, “that hitting biomedical research now is going to have an impact, three, four years from now.” So efforts to let […]

Physicians, researchers, advocates tell Obama and Congress: Gaps in President’s budget request will reverse gains

By on .

Three weeks after President Obama’s budget proposal for fiscal year 2014 appeared, sustaining support for the Global Fund to Fight AIDS Tuberculosis and Malaria, while cutting funds to the President’s Emergency Plan For AIDS Relief, and hacking global TB funding, physicians, scientists, and global health advocates are weighing in. And while United States Agency for […]

TB Week: What We’re Reading is all about tuberculosis — the impact on children, a manifesto, upcoming films, trends in the US and more . . .

By on .

We can heal: The title of this story compilation from 30 children grappling with tuberculosis in 30 countries, are the words of a girl in Colombia, who recovered from the disease but lost much of her hearing to the treatment. The stories and photos of children losing their health, youth, and lives to a preventable […]

US TB drug shortages highlight global gaps

By on .

This is how small the world of infectious diseases can be, and how recent the distant past. The patient who ended up at Baltimore’s Health Department in April 2011 had been treated with apparent success for tuberculosis before, in Kenya, where he was from. But now, he had a strain of the disease that was […]

FDA TB drug approval a milestone, with caveats

By on .

The U.S. Food and Drug Administration’s approval of the first new drug to treat tuberculosis in nearly half a century and the agency’s first use of its accelerated approval process to speed availability of TB medicine comes with cautions, and with a direction of work yet to be done, agency officials and treatment advocates agree. […]

FDA panel finds new type of TB drug effective, raising hopes for treatment of drug-resistant strains

By on .

Dr. Dalene von Delft had a choice between dying  or going deaf, and that was a choice only if the arduous treatment she was undergoing for drug-resistant tuberculosis worked. The South African pediatrician had contracted a resistant strain of the disease caring for patients, and the only potentially effective treatment was showing one of its […]

Blueprint: Support community efforts, strengthen systems, improve delivery and ensure funding

By on .

David Barr began working on HIV/AIDS issues in 1985. He coordinated the creation of the HIV Collaborative Fund, a partnership of the International Treatment Preparedness Coalition (ITPC) and Tides Foundation, which to date has supported more than 1,000 organizations in over 70 countries with small grants and capacity-building for HIV treatment awareness, literacy, community mobilization […]